Federal Register / Vol. 63, No. 88 /Thursday, May 7, 1998 / Notices 25225

adversely affects human health.

Additional details of this program are

found in Federal Register December 16,

1997, (Volume 62, No. 241, pp. 65814–

65815).

Working Group Meeting on EMF Health

Effects Research Open to the Public

The next phase of the NIEHS report

development process includes a

Working Group meeting of scientists

from multiple disciplines. The Working

Group members are tasked with writing

a comprehensive review of the literature

on the potential for extremely low

frequency EMF to affect human health.

This document will draw conclusions

on the strength and robustness of the

data and its implications for human

health effects and disease etiology. This

meeting is scheduled for June 15–24,

1998, at the Northland Inn, Brooklyn

Park, Minnesota, and is open to the

public.

Detailed information about the

EMFRAPID Program is found on the

world wide web at www.niehs.nih.gov/

emfrapid/home.htm. For additional

information about the Working Group

meeting, send a request by fax to 919–

541–0144 or by mail to EMFRAPID

Program, LCBRA, NIEHS, NIH, PO Box

12233 MS EC–16, Research Triangle

Park, NC 27709, or call 919–541–7534.

Dated: April 30, 1998.

Samuel H. Wilson,

National Institute of Environmental Health

Sciences.

[FR Doc. 98–12177 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Warren Grant Magnuson Clinical

Center; Notice of Meeting of the Board

of Governors of the Warren Grant

Magnuson Clinical Center

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the Board of Governors of the Warren

Grant Magnuson Clinical Center, May

27, 1998. The Board of Governors will

meet at the National Institutes of Health,

Clinical Center (Building 10), Medical

Board Room (2C116), 9000 Rockville

Pike, Bethesda, Maryland, from 9:00

a.m. until approximately 12:30 p.m.

The entire meeting will be open to the

public and will include review of the

minutes of the March 23, 1998

Executive Committee meeting, updates

on the budget, strategic planning, and

the Clinical Research Center.

Attendance by the public will be

limited to space available.

For further information, contact Ms.

Maggi Stakem, Office of the Director,

Warren Grant Magnuson Clinical

Center, Building 10, Room 2C146,

Bethesda, Maryland 20892, (301) 496–

4114.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Stakem in advance of the

meeting.

Dated: May 1, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12102 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: Container for Drying

Biological Samples, Method of Making

Such Container, and Method of Using

Same

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This is notice in accordance

with 15 U.S.C. 209(c)(1) and 37 CFR

404.7(a)(1)(I) that the National Institutes

of Health (NIH), Department of Health

and Human Services, is contemplating

the grant of an exclusive worldwide

license to practice the invention

embodied in U.S. Patent Applicant SN

08/717,114 entitled ‘‘Container for

Drying Biological Samples, Method of

Making Such Container, and Method of

Using Same’’ and related U.S. and

foreign patent applications to Whatman,

Incorporated of Clifton, New Jersey. The

patent rights in this invention have been

assigned to the United States of

America.

Is is anticipated that this license may

be limited to the field of sales to;

biotechnology labortories, and original

equipment manufacturers of

diagnostics.

DATES: Only written comments and/or

applications for a license which are

received by the NIH Office of

Technology Transfer on or before July 6,

1998 will be considered.

ADDRESSES: Requests for a copy of this

patent application, inquiries, comments

and other materials relating to the

contemplated license should be directed

to: David R. Sadowski, Technology

Transfer Specialist, Office of

Technology transfer, National Institutes

of Health, 6011 Executive Boulevard,

Suite 325, Rockville, MD 20852;

Telephone (301) 496–7056 extension

288; Facsimile: (301) 401–0220; E-mail

ds27a@nih.gov. A signed Confidential

Disclosure Agreement will be required

to receive a copy of the patent

application.

SUPPLEMENTARY INFORMATION: The patent

application describes a method (and

associated device) for venting a sample

which is in a container, the method

comprising: providing a container

having an opening, the opening being

sealed substantially with a filter. The

filter permitting permeation

therethrough of at least one gas and

substantially preventing permeation

therethrough of microbes. Wherein said

container is configured to withstand

high speed centrifugation of 50 or more

times the force of gravity. Thus, gas is

permitted to enter or exit the container

by permeating the filter, thereby

affording venting of the sample without

substantial contamination of the sample

with microbes. More broadly, this

invention permits the lyophilization or

venting or other permeation of gas into,

or out of, a container, while preventing

contamination of a sample which is

within the container.

The prospective exclusive license will

be royalty-bearing and will comply with

the terms and conditions of 35 U.S.C.

209 and 37 CFR 404.7. This prospective

exclusive license may be granted unless

within 60 days from the date of this

published notice, NIH receives written

evidence and argument that establishes

that the grant of the license would not

be consistent with the requirements of

35 U.S.C. 209 and 37 CFR 404.7.

Applications for a license filed in

response to this notice will be treated as

objections to the grant of the

contemplated license. Comments and

objections submitted in response to this

notice will be not made available for

public inspection, and, to the extent

permitted by law, will not be released

under the Freedom of Information Act,

5 U.S.C. 552.

Dated: April 29, 1998.

Jack Spiegel,

Director, Division of Technology Development

and Transfer, Office of Technology Transfer.

[FR Doc. 98–12108 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M